Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era, Circulation, vol.122, issue.2, pp.156-163, 2010. ,
DOI : 10.1161/CIRCULATIONAHA.109.911818
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension, European Respiratory Journal, vol.36, issue.3, pp.549-555, 2010. ,
DOI : 10.1183/09031936.00057010
URL : https://hal.archives-ouvertes.fr/hal-00929872
The Cancer Paradigm of Severe Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.6, pp.558-564, 2008. ,
DOI : 10.1164/rccm.200709-1369PP
Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents, Journal of Clinical Investigation, vol.119, issue.3, pp.512-523, 2009. ,
DOI : 10.1172/JCI35070
URL : https://hal.archives-ouvertes.fr/inserm-00499635
Epidermal Growth Factor Receptor Blockade Mediates Smooth Muscle Cell Apoptosis and Improves Survival in Rats With Pulmonary Hypertension, Circulation, vol.112, issue.3, pp.423-431, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.105.540542
Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.1, pp.81-88, 2008. ,
DOI : 10.1164/rccm.200707-1037OC